Stocks · Health care · Biological Products, (No Diagnostic Substances)

PALISADE BIO, INC.

PALI Clue Score57
United States Fiscal year ends December CIK 0001357459 Results filed 10 Aug 2026

What the insiders did No buying or selling

By person

8 insiders · 0 transactions
5.3×

J.D. Finley holds 5.3 times base salary in stock. $3.10M of shares against $575.00K in salary for 2025.

Salary from the company's own proxy. The shares are what J.D. Finley last reported holding, valued at $1.46, the price Common Stock was last bought or sold at on the open market here, on 2 Oct 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
John David Finley
CEO CFO
—
—
—
2,121,592
$3.10M
+1,860%
Mitchell Lawrence Jones
See Remarks
—
—
—
1,683,757
$2.46M
+19,229%
Donald Allen Williams
Director
—
—
—
1,593,294
$2.33M
+47,603%
Julien E. Capers
See Remarks
—
—
—
787,300
$1.15M
—
Binxian Wei
Director
—
—
—
613,355
$895.50K
+131,239%
Emil Chuang
Director
—
—
—
612,500
$894.25K
—
Robert Baltera Jr.
Director
—
—
—
461,904
$674.38K
—
Jordan Michael Zwick
Director
—
—
—
336,904
$491.88K
—

No percentages here. This company's share count has moved by a factor of 39.6 over the window, from 4,396,646 to 174,270,558 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.